feedback welcome

Mirtazapine-clomipramine

From Psychiatrynet

(Difference between revisions)
Jump to:navigation, search
[checked revision][checked revision]
Line 3: Line 3:
| to = clomipramine  
| to = clomipramine  
| stop =  
| stop =  
-
* '''Before day 1:''' gradually reduce dosage of mirtazapine to a maximum of 30 mg/ day.
+
{{stopMirtazapine}}
-
* '''Day 1:''' reduce a dosage of 30 mg/day to 15 mg/day.
+
| start =  
-
| start =
+
{{Inc25p3d2}}
-
No wash-out period is needed.
+
* Start administration of clomipramine in a dosage of 75 mg/day.  
-
* '''Day 1:''' simultaneously start administration of clomipramine in a dosage of 75 mg/day.
+
-
* '''Day 8:''' stop administration of mirtazapine and continue administration of clomipramine. If necessary, increase dosage of clomipramine.
+
* Start low, go slow.
* Start low, go slow.
| info =
| info =
-
{{review}}
+
* No wash-out period is needed.
}}
}}

Revision as of 10:53, 14 October 2015

Mirtazapine
Type Antidepressant
Group other
links
Medscape Mirtazapine
PubChem 4205
PubMed Mirtazapine
Kompas (Dutch) Mirtazapine
Wikipedia Mirtazapine
Clomipramine
Type Antidepressant
Group TCA
links
ATC-code N06AA04
Medscape Clomipramine
PubChem 2801
PubMed Clomipramine
Kompas (Dutch) Clomipramine
Wikipedia Clomipramine

Switch medication from mirtazapine to clomipramine.

Nietinrijdenbord.png Stop mirtazapine
Eenrichtingbord.png Start clomipramine
Infobord.png More information
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
Navigation
About